ZP
KLRS

Zimmer Partners’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History

Zimmer Partners’s Portfolio KLRS Stock Details KLRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-1,087
Closed -$688K – 171
2020
Q3 		$688K Buy
+1,087
New +$688K 0.01% 100